About Us Team Pipeline News Contact Us Home

Kinex raises more than $3 million in equity financing

Kinex Co-Founder Appointed to NYBA Board

Kinex Awarded US Patent

Start of Clinical Trial for KX2-391

KX2-391 Enters Phase 1 Clinical Trials for Oncology

More headlines ...

Pipeline

Kinex will develop its current leads and leverage its technology platform to build a pipeline of clinical candidates that address large market opportunities and unmet medical needs.

Programs         Target Indication Discovery Research Pre-Clinical Clinical Trials Src Cancer Src Hearing Loss     LCK Immunology       ZAP70 Arthritis       FAK Opthalmic Disease     JAK Inflammation

©2007 Kinex Pharmaceuticals. All rights reserved.